The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure

Archives of Internal Medicine

Volumn 148, Issue 5, 1988, Pages 1023-1038

 

^a National High Blood Pressure Education   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CHOLESTEROL; CLONIDINE; DILTIAZEM; ENALAPRIL; GUANABENZ; GUANETHIDINE; GUANFACINE; HYDRALAZINE; MINOXIDIL; NIFEDIPINE; NITRENDIPINE; PRAZOSIN; PROPRANOLOL; RAUWOLFIA ALKALOID; TERAZOSIN; THIAZIDE DIURETIC AGENT; VERAPAMIL;

ADULT; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRAINING;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHILD; FEMALE; HEALTH PROMOTION; HUMAN; HYPERTENSION; MEDICAL HISTORY TAKING; MIDDLE AGE; PHYSICAL EXAMINATION; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; QUALITY OF LIFE; UNITED STATES;

EID: 0023942157     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1988.00380050029006     Document Type: Article

References (54)

1. 1. Subcommittee on Definition and Prevalence of the 1984 Joint National Committee: Hypertension prevalence and the status of awareness, treatment, and control in the United States: Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee. Hypertension 1985;7:457-468.
2. 2. Frohlich ED, Grim C, Labarthe DR, et al: Report of a special task force appointed by the Steering Committee, American Heart Association: Recommendations for human blood pressure determinations by sphygmomanometers. Hypertension 1988;11:209A-222A.
3. 3. Hunt JC, Frohlich ED, Moser M, et al: Devices used for self-measurement of blood pressure: Revised statement of the National High Blood Pressure Education Program. Arch Intern Med 1985;145:2231-2234.
4. 4. Working Group on Renovascular Hypertension: Detection, evaluation, and treatment of renovascular hypertension: Final report. Arch Intern Med 1987;147:820-829.
5. 5. Nonpharmacological approaches to the control of high blood pressure: Final report of the Subcommittee on Nonpharmacological Therapy of the 1984 Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 1986;8:444-467.
6. 6. Aristimuno GG, Foster TA, Voors AW, et al: Influence of persistent obesity in children on cardiovascular risk factors: The Bogalusa Heart Study. Circulation 1984;69:895-904.
7. 7. MacMahon SW, Norton RN: Alcohol and hypertension: Implications for prevention and treatment. Ann Intern Med 1986;105:124-125.
8. 8. Weinberger MH, Miller JZ, Luft FC, et al: Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension 1986;8(suppl 2):127-134.
9. 9. James WPT, Ralph A, Sánchez-Castillo CP: The dominance of salt in manufactured food in the sodium intake of affluent societies. Lancet 1987;1:426-429.
10. 10. Kihara M, Fujikawa J, Ohtaka M, et al: Interrelationships between blood pressure, sodium, potassium, serum cholesterol, and protein intake in Japanese. Hypertension 1984;6:736-742.
11. 11. MacGregor GA, Smith SJ, Markandu ND, et al: Moderate potassium supplementation in essential hypertension. Lancet 1982;2:567-570
12. 12. McCarron DA, Morris CD: Blood pressure response to oral calcium in persons with mild to moderate hypertension: A randomized, double-blind, placebo-controlled, crossover trial. Ann Intern Med 1985;103:825-831.
13. 13. Kestleloot H, Geboers J, Van Hoof R: Epidemiologic study of the relationship between calcium and blood pressure. Hypertension 1983;5(suppl 2):52-56.
14. 14. Dawber TR: The Farmingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge, Mass, Harvard University Press, 1980, pp 172-189.
15. 15. Management Committee of the Australian National Blood Pressure Study: Prognostic factors in the treatment of mild hypertension. Circulation 1984;69:668-676.
16. 16. Isles C, Brown JJ, Cumming AMM, et al: Excess smoking in malignant-phase hypertension. Br Med J Clin Res 1979;1:579-581.
17. 17. Bonita R: Cigarette smoking, hypertension, and the risk of subarachnoid hemorrhage: A population-based, case-control study. Stroke 1986;17:831-835.
18. 18. Greenberg G, Thompson SG, Brennan PJ: The relationship between smoking and the response to antihypertensive treatment in mild hypertensives in the Medical Research Council’s trial of treatment. Int J Epidemiol 1987;16:25-30.
19. 19. Working Group on Physician Behaviors to Reduce Smoking Among Hypertensive Patients: The Physician’s Guide: How to Help Your Hypertensive Patients Stop Smoking, US Dept of Health and Human Services publication (NIH) 84-1271. National High Blood Pressure Education Program, 1984.
20. 20. Health and Public Policy Committee, American College of Physicians: Biofeedback for hypertension. Ann Intern Med 1985;102:709-715.
21. 21. Patel C, Marmot MG, Terry DJ, et al: Trials of relaxation in reducing coronary risk: Four-year follow-up. Br Med J Clin Res 1985;290:1103-1106.
22. 22. Engel BT, Glasgow MS, Gaarder KR: Behavioral treatment of high blood pressure: III. Follow-up results and treatment recommendations. Psychosom Med 1983;45:23-29.
23. 23. Iacono JM, Dougherty RM, Puska P: Reduction of blood pressure associated with dietary polyunsaturated fat. Hypertension 1982;4(suppl 3):34-42.
24. 24. Sacks FM, Stampfer MJ, Múñoz A, et al: Effect of linoleic and oleic acids on blood pressure, blood viscosity, and erythrocyte cation transport. J Am Coll Nutr 1987;6:179-185.
25. 25. Veterans Administration Cooperative Study Group on Antihypertensive Agents: Effects of treatment on morbidity in hypertension: III. Influence of age, diastolic pressure, and prior cardiovascular disease: Further analysis of side effects. Circulation 1972;45:991-1004.
26. 26. Hypertension Detection and Follow-Up Program Cooperative Group: Five-year findings of the Hypertension Detection and Follow-Up Program: I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 1979;242:2562-2572.
27. 27. Management Committee of the Australian National Blood Pressure Study: The Australian therapeutic trial in mild hypertension. Lancet 1980;1:1261-1267.
28. 28. Medical Research Council Working Party: MRC trial of treatment of mild hypertension: Principal results. Br Med J Clin Res 1985;291:97-104.
29. 29. MacMahon SW, Cutler JA, Furberg CD, et al: The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: A review of randomized, controlled trials. Prog Cardiovasc Dis 1986;29(suppl):99-118.
30. 30. Cruickshank JM, Thorp JM, Zacharias FJ: Benefits and potential harm of lowering high blood pressure. Lancet 1987;1:581-583.
31. 31. The 1984 Joint National Committee: The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984;144:1045-1057.
32. 32. Stamler R, Stamler J, Grimm R, et al: Nutritional therapy for high blood pressure: Final report of a four-year randomized, controlled trial— The Hypertension Control Program. JAMA 1987;257:1484-1491.
33. 33. Cutler J, Horan M, Roccella EJ: Proceedings of the workshop on antihypertensive drug therapy: The benefits, costs, and choices. Hypertension, in press.
34. 34. Working Group on Hypertension in the Elderly: Statement on hypertension in the elderly. JAMA 1986;256:70-74.
35. 35. Levine DM, Green LW, Deeds SG, et al: Health education for hypertensive patients. JAMA 1979;241:1700-1703.
36. 36. Morisky DE, Levine DM, Green LW, et al: Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health 1983;73:153-162.
37. 37. Haynes RB, Dantes R: Patient compliance and the conduct and interpretation of therapeutic trials. Controlled Clin Trials 1987;8:12-19.
38. 38. Mullen PD, Green LW, Persinger GS: Clinical trials of patient education for chronic conditions: A comparative meta-analysis of intervention types. Prev Med 1985;14:753-781.
39. 39. Working Group on Health Education and High Blood Pressure Control, National High Blood Pressure Education Program: The Physician’s Guide: Improving Adherence Among Hypertensive Patients, US Dept of Health and Human Services publication. Bethesda, Md, National Heart, Lung, and Blood Institute, 1987.
40. 40. Shulman NB, Martinez B, Brogan D, et al: Financial cost as an obstacle to hypertension therapy. Am J Public Health 1986;76:1105-1108.
41. 41. Thornberry OT, Wilson RW, Golden PM: Health Promotion Data for the 1990 Objectives: Estimates From the National Health Interview Survey of Health Promotion and Disease Prevention, United States 1985, US Dept of Health and Human Services publication (PHS) 86-1250. National Center for Health Statistics, 1986, Advance Data No. 126.
42. 42. National High Blood Pressure Education Program: Patient Tracking for High Blood Pressure Control, US Dept of Health and Human Services publication (NIH) 84-2204. Bethesda, Md, National Heart, Lung, and Blood Institute, 1984.
43. 43. National High Blood Pressure Education Program: Measuring Progress in High Blood Pressure Control: An Evaluation Handbook, US Dept of Health and Human Services publication (NIH) 86-2647. Bethesda, Md, National Heart, Lung, and Blood Institute, 1986.
44. 44. Amery A, Birkenhager W, Brixko P, et al: Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;1:1349-1354.
45. 45. Curb JD, Borhani NO, Blaszkowski TP, et al: Long-term surveillance for adverse effects of antihypertensive drugs. JAMA 1985;253:3263-3268.
46. 46. Hulley SB, Furberg CD, Gurland B, et al: Systolic Hypertension in the Elderly Program (SHEP): Antihypertensive efficacy of chlorthalidone. Am J Cardiol 1985;56:913-920.
47. 47. Report of the second Task Force on Blood Pressure Control in Children—1987. Pediatrics 1987;79:1-25.
48. 48. Cutler J, MacMahon S, Furberg C: Controlled clinical trials of drug treatment for hypertension: A review. Hypertension, in press.
49. 49. The Expert Panel: Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988;148:36-69.
50. 50. Cohn JN, Archibald DG, Ziesche S, et al: Effect of vasodilator therapy on mortality in chronic congestive heart failure: Results of a Veterans Administration cooperative study. N Engl J Med 1986;314:1547-1552.
51. 51. Frohlich ED: Cardiac hypertrophy in hypertension. N Engl J Med 1987;317:831-833.
52. 52. MacMahon SW, Wilcken DEL, MacDonald GJ: The effect of weight reduction on left ventricular mass. N Engl J Med 1986;314:334-339.
53. 53. Working Group on Hypertension in Diabetes: Statement on hypertension in diabetes mellitus: Final report. Arch Intern Med 1987;147:830-842.
54. 54. Weidmann P, Uehlinger DE, Gerber A: Antihypertensive treatment and serum lipoproteins. J Hypertens 1985;3:297-306.